|  | < 90% drug adherence | Univariate | Adjusted | ||||
---|---|---|---|---|---|---|---|---|
 | N | n | % | OR | 95% CI | p-value | OR | 95% CI |
Province | Â | Â | Â | Â | Â | 0.02 | Â | Â |
Anhui | 105 | 11 | 10.5% | 1.00 | Â | Â | Â | Â |
Ningxia | 104 | 0 | 0% | -- | -- | Â | Â | Â |
Jiangxi | 105 | 9 | 8.6% | 0.80 | 0.32-2.02 | Â | Â | Â |
Guizhou | 105 | 22 | 21.0% | 2.27 | 1.04-4.95 | Â | Â | Â |
Ganshu | 105 | 7 | 6.7% | 0.61 | 0.23-1.64 | Â | Â | Â |
Education level | Â | Â | Â | Â | Â | 0.04 | Â | Â |
No formal education | 142 | 7 | 4.9% | 1.00 | Â | Â | Â | Â |
At least primary school | 382 | 42 | 11.0% | 2.38 | 1.04-5.43 | Â | Â | Â |
TB patient category | Â | Â | Â | Â | Â | 0.20 | Â | Â |
New | 476 | 42 | 8.8% | 1.00 | Â | Â | Â | Â |
Retreatment | 48 | 7 | 14.6% | 1.76 | 0.75-4.18 | Â | Â | Â |
Adverse effects during treatment | Â | Â | Â | Â | Â | < 0.01 | Â | Â |
Yes | 312 | 41 | 13.1% | 1.00 | Â | Â | 1.00 | Â |
No | 212 | 8 | 3.8% | 0.26 | 0.12-0.57 | Â | 0.30 | 0.17-0.53 |
DOT during the intensive phase | Â | Â | Â | Â | Â | < 0.01 | Â | Â |
no DOT | 241 | 33 | 13.7% | 1.00 | Â | Â | 1.00 | Â |
DOT by village doctors | 153 | 5 | 3.3% | 0.21 | 0.08-0.56 | Â | 0.28 | 0.09-0.82 |
DOT by volunteers | 130 | 11 | 8.5% | 0.58 | 0.28-1.20 | Â | 0.44 | 0.19-1.03 |
DOT during continuation phase | Â | Â | Â | Â | Â | 0.02 | Â | Â |
no DOT | 253 | 31 | 12.3% | 1.00 | Â | Â | Â | Â |
DOT by village doctors | 136 | 4 | 2.9% | 0.22 | 0.08-0.63 | Â | Â | Â |
DOT by volunteers | 135 | 14 | 10.4% | 0.83 | 0.42-1.62 | Â | Â | Â |
Supervision visits by (village) doctor during treatment | Â | Â | Â | Â | Â | < 0.001 | Â | Â |
Yes | 462 | 35 | 7.6% | 1.00 | Â | Â | Â | Â |
No | 62 | 14 | 22.6% | 3.56 | 1.79-7.08 | Â | Â | Â |
Time DOT observer spends with the patient during observation of treatment | Â | Â | Â | Â | Â | 0.003 | Â | Â |
DOT at home, ≤10 minutes | 181 | 10 | 5.5% | 1.00 |  |  | 1.00 |  |
DOT at home, > 10 minutes | 198 | 15 | 7.6% | 1.40 | 0.61-3.20 | Â | 2.10 | 0.82-5.42 |
DOT outside home or no DOT | 145 | 24 | 16.6% | 3.39 | 1.57-7.35 | Â | 3.49 | 1.42-8.62 |